Treatment of Pseudomonas UTI in Patients with Quinolone Allergy

First-Line Treatment Options

Piperacillin-tazobactam is an effective option for susceptible Pseudomonas strains, according to Praxis Medical Insights 1

For non-severe UTI, Fosfomycin IV is recommended with high certainty of evidence, as stated by Clinical Microbiology and Infection 2
For non-severe UTI, Aminoglycosides can be considered for short-duration therapy without septic shock, as stated by Clinical Microbiology and Infection 2

Cefepime, at a higher dose, is recommended for severe UTI, according to European Urology 3
Piperacillin-tazobactam is also recommended for severe UTI, according to European Urology 3

Combination therapy should be considered for critically ill patients with suspected Pseudomonas infection, as recommended by Praxis Medical Insights 1
The recommended combination is an antipseudomonal β-lactam plus an aminoglycoside, according to Praxis Medical Insights 1
The duration of therapy is 7-10 days for uncomplicated infections and 10-14 days for complicated or bloodstream infections, as stated by Praxis Medical Insights 1

Ceftolozane/tazobactam or ceftazidime/avibactam can be considered for difficult-to-treat resistant Pseudomonas, according to Praxis Medical Insights 1

Aminoglycoside monotherapy should be avoided except for uncomplicated UTIs due to potential nephrotoxicity and ototoxicity, as warned by Praxis Medical Insights and Clinical Infectious Diseases 1, 4
Renal function should be monitored closely when using aminoglycosides or high-dose β-lactams, as advised by Clinical Infectious Diseases 4
For patients who have received recent antibiotic therapy, an alternative class of antibiotics should be considered to prevent resistance development, according to Praxis Medical Insights 1

Oral options can be considered once the patient improves clinically and susceptibility results are available, as recommended by Clinical Microbiology and Infection 2
For patients with persistent symptoms after 5-7 days of appropriate therapy, imaging should be considered to rule out complications, as suggested by Clinical Microbiology and Infection 2